Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Neuroimmunology|January 15, 2000
Dopamine, a neurotransmitter, influences the immune systemS Basu, P S DasguptaNeoplasma|January 1, 1992
Alteration of brain catecholamines during growth of benzo(a)pyrene induced murine fibrosarcomaP S Dasgupta, T LahiriDigestive Diseases and Sciences|June 1, 1997
Alteration of dopamine D2 receptors in human malignant stomach tissueS Basu, P S DasguptaJournal of Cancer Research and Clinical Oncology|January 1, 1987
Antitumor effect of i.p. dopamine in mice bearing Ehrlich ascites carcinomaP S Dasgupta, T LahiriDigestive Diseases and Sciences|May 11, 1999
Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissueS Basu, P S DasguptaIndian Journal of Experimental Biology|January 1, 1991
Decrease in dopamine and norepinephrine concentration in different brain regions of mice during progression of Sarcoma 180 tumourP S Dasgupta, T LahiriJournal of Neuroimmunology|July 1, 1995
Enhanced tumor growth in brain dopamine-depleted mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatmentS Basu, P S Dasgupta, J R ChowdhuryNeoplasma|January 1, 1990
Tumor inhibition and hematological improvements by dopamine analog 3,4-dihydroxybenzylamine in mice bearing transplantable carcinomaT Lahiri, S Banerjee, P S Dasgupta, et al.International Immunopharmacology|July 20, 2001
Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysisB Saha, A C Mondal, S Basu, et al.Pageof 2